SCHEMBL7093589

SCHEMBL7093589

CC(C)(C)c1cc2c(c(C(C)(C)C)c1)OC(=O)/C2=C1/Nc2ccccc2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 2/20 0.38
CASP3 P42574 2/20 0.38
RAB9A P51151 2/20 0.38
SENP8 Q96LD8 2/20 0.38
SENP7 Q9BQF6 2/20 0.38
SENP6 Q9GZR1 2/20 0.38
PLA2G1B P04054 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
GABBR2 O75899 1/20 0.36
GABBR1 Q9UBS5 1/20 0.36
ERBB2 P04626 3/20 0.36
EGFR P00533 2/20 0.36
IGF1R P08069 1/20 0.36
MAPT P10636 4/20 0.35
TP53 P04637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7093590 1.00 ALDH1A1 (0.38) ALDH1A1NPC1CASP3RAB9ASENP8
SCHEMBL7090188 0.85 ERBB2 (0.38) ALDH1A1RAB9AL3MBTL1ERBB2EGFR
SCHEMBL7090186 0.85 ERBB2 (0.38) ALDH1A1RAB9AL3MBTL1ERBB2EGFR
SCHEMBL7090165 0.84 ERBB2 (0.41) ALDH1A1NPC1CASP3RAB9ASENP8
SCHEMBL7090167 0.84 ERBB2 (0.41) ALDH1A1NPC1CASP3RAB9ASENP8
SCHEMBL7155129 0.79 GABBR2 (0.44) ALDH1A1NPC1CASP3RAB9ASENP8
SCHEMBL13656879 0.79 GABBR2 (0.44) ALDH1A1NPC1CASP3RAB9ASENP8
SCHEMBL6306524 0.73 GABBR2 (0.44) ALDH1A1NPC1CASP3RAB9ASENP8
SCHEMBL7090861 0.71 NR1H3 (0.45) ALDH1A1NPC1CASP3RAB9ASENP8
SCHEMBL7089170 0.70 MAOA (0.47) ALDH1A1MAPTMAOAMAOBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030121113-A1 Oxobenzofuranylide-dihydroindolone NESVADBA PETER (CH) 2003-07-03 US disclosed
US-6503937-B1 Coloring agents for high molecular weight materials such as polymers CIBA SPECIALTY CHEMICALS CORPORATION 2003-01-07 US disclosed
EP-1123289-B1 OXOBENZOFURANYLIDE-DIHYDROINDOLONES CIBA SC HOLDING AG (CH) 2002-11-27 EP disclosed
EP-1123289-A1 OXOBENZOFURANYLIDE-DIHYDROINDOLONE Ciba SC Holding AG (CH) 2001-08-16 EP disclosed
WO-2000024736-A1 OXOBENZOFURANYLIDE-DIHYDROINDOLONE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030121113-A1 Oxobenzofuranylide-dihydroindolone CYP1B1, CYP1A1, ECI1 ALDH1A1 225/4885NPC1 2435/4885CASP3 1316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.